Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Primary Myelofibrosis × durvalumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 23 Lung Neoplasms 17 Small Cell Lung Carcinoma 9 Urinary Bladder Neoplasms 6 Neoplasms 6 Carcinoma, Hepatocellular 6 Cholangiocarcinoma 5 Biliary Tract Neoplasms 5 Liver Neoplasms 4 Neoplasms by Site 3 Triple Negative Breast Neoplasms 2 Thoracic Neoplasms 2 Stomach Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Lung Diseases 2 Gallbladder Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Bronchogenic 2 Carcinoma 2 Bronchial Neoplasms 2 Breast Neoplasms 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1

Interventions

ruxolitinib 5 fludarabine 3 Cyclophosphamide 3 Whole-Body Irradiation 2 Tacrolimus 2 Stem Cell Transplantation 2 Specimen Handling 2 venetoclax 1 veliparib 1 selinexor 1 pevonedistat 1 merphos 1 iadademstat 1 fludarabine phosphate 1 fedratinib 1 decitabine and cedazuridine drug combination 1 bomedemstat 1 Topotecan 1 Panobinostat 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Janus Kinase Inhibitors 1 Injections 1 INCB057643 1 Granulocyte Colony-Stimulating Factor 1 Decitabine 1 Cyclosporine 1 Carboplatin 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡